Healthcare -
Biotechnology - NASDAQ - US
$ 3.6
2.86 %
$ 308 M
Market Cap
-0.94
P/E
AMLX - SHORT-TERM DEBT
Short-term Debt AMLX - Amylyx Pharmaceuticals, Inc.
2.26 M
LAST VALUE
0.00%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR